Immuno-gene therapy of cancer with tumour-mRNA transfected dendritic cells.
about
Immunotherapy in gastric cancerConcise Review: Cell-Based Therapies and Other Non-Traditional Approaches for Type 1 DiabetesA full scale comparative study of methods for generation of functional Dendritic cells for use as cancer vaccines.Advancement and prospects of tumor gene therapyInduction of cytotoxic T lymphocytes primed with tumor RNA-loaded dendritic cells in esophageal squamous cell carcinoma: preliminary step for DC vaccine design.Dendritic cell-based human immunodeficiency virus vaccine.Strategies for cancer vaccine development.Comparative analysis of cytotoxic T lymphocyte response induced by dendritic cells loaded with hepatocellular carcinoma -derived RNA or cell lysate.Examination of MARCO activity on dendritic cell phenotype and function using a gene knockout mouseUpdate on prostate cancer vaccinesTrial watch: Dendritic cell-based interventions for cancer therapyAdenovirus MART-1-engineered autologous dendritic cell vaccine for metastatic melanoma.Cutaneous delivery of prophylactic and therapeutic vaccines: historical perspective and future outlook.Dendritic cell-based vaccines for the therapy of experimental tumors.Dendritic cell preparation for immunotherapeutic interventions.Genetically modified dendritic cells in cancer immunotherapy: a better tomorrow?Paradigm Shift in Dendritic Cell-Based Immunotherapy: From in vitro Generated Monocyte-Derived DCs to Naturally Circulating DC Subsets.Immunotherapy for prostate cancer: lessons from responses to tumor-associated antigens.Prostate cancer immunotherapy, particularly in combination with androgen deprivation or radiation treatment. Customized pharmacogenomic approaches to overcome immunotherapy cancer resistance.Allogeneic mRNA-based electrotransfection of autologous dendritic cells and specific antitumor effects against osteosarcoma in rats.Androgen ablation augments prostate cancer vaccine immunogenicity only when applied after immunization.Phosphorothioate cap analogs increase stability and translational efficiency of RNA vaccines in immature dendritic cells and induce superior immune responses in vivo.International Society for Cell and Gene Therapy of Cancer: 2005 meeting in Shenzhen, China.Transfer of mRNA encoding recombinant immunoreceptors reprograms CD4+ and CD8+ T cells for use in the adoptive immunotherapy of cancer.CD40 Ligand-activated, antigen-specific B cells are comparable to mature dendritic cells in presenting protein antigens and major histocompatibility complex class I- and class II-binding peptides.Direct and indirect antitumor effects by human peripheral blood lymphocytes expressing both chimeric immune receptor and interleukin-2 in ovarian cancer xenograft model.The Pattern of Signatures in Gastric Cancer Prognosis.
P2860
Q27010472-D33B7892-3360-4C03-B05C-49509736E754Q28071490-3CBCA40A-6BB9-49C1-86CB-E647E669941EQ33289806-2BAFC8F3-A2B4-4A9A-B233-FC5C51A469F7Q33579330-203DB704-A117-403A-822A-060F23C9FB56Q33595455-B77D8282-D4AB-4C94-8826-7F13CD7EDFA1Q33874652-5529AAAD-286C-4BCA-95F7-B08CB15D5672Q34038338-2C2104B7-14C4-4C8E-955A-0CAAB9918171Q34231139-E0889BC1-F37F-4FA4-A951-A13ABBDAD255Q34809052-3F1D9343-05D7-406F-84FB-66F06B139406Q36169608-D8DE8B16-4C38-4C99-A603-036E15C24097Q36388529-3982437E-5C86-4A18-B568-174D28243768Q36834545-64EF97FA-85A5-417B-9A34-BA7A0AD875FEQ37316009-94ADD04F-F6F5-4A43-8B23-B4A8D4F20B31Q37773259-A6A98A72-0960-4A35-819D-5002FC79007AQ37773266-46294F1A-0576-4872-B95D-DC2342B7EE94Q37800934-B594B136-8BAC-4BE2-A31D-453CEBD9442AQ38208309-A6F5C655-9F8D-4F1D-84FC-3D8D4C332FE7Q38212231-03300DEA-AF97-4948-87A3-D05005E58CB3Q39093352-6D86DA0B-0159-44D6-B9F7-AD1F89D5108BQ39306532-A44FF930-0846-4871-81DA-5D1EDD53F9DCQ42536013-6F363D08-2E4C-4712-9242-7D3CFAEC319CQ45858586-D5F9B672-75FA-4CFA-8175-AC3D99520333Q45863162-17B7075C-7FB8-4279-8CD8-27B089A673E9Q45882718-3DD0FBA5-0372-49E1-8FAB-E639094E1CDAQ48371221-F259D60F-A148-4486-921F-DBA3A6A9AC20Q54667188-7FA7C9BD-8DD0-4FC7-93A7-17148E2D08F4Q55618345-3F2511E3-78DA-4CA4-91F2-3C6A16E7D463
P2860
Immuno-gene therapy of cancer with tumour-mRNA transfected dendritic cells.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh
2006年學術文章
@zh-hant
name
Immuno-gene therapy of cancer with tumour-mRNA transfected dendritic cells.
@ast
Immuno-gene therapy of cancer with tumour-mRNA transfected dendritic cells.
@en
type
label
Immuno-gene therapy of cancer with tumour-mRNA transfected dendritic cells.
@ast
Immuno-gene therapy of cancer with tumour-mRNA transfected dendritic cells.
@en
prefLabel
Immuno-gene therapy of cancer with tumour-mRNA transfected dendritic cells.
@ast
Immuno-gene therapy of cancer with tumour-mRNA transfected dendritic cells.
@en
P1476
Immuno-gene therapy of cancer with tumour-mRNA transfected dendritic cells.
@en
P2093
Jon A Kyte
P2860
P2888
P304
P356
10.1007/S00262-006-0161-7
P577
2006-04-13T00:00:00Z